
Leigh C. Maier
Examiner (ID: 12110, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1614, 1621, 1693 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13369177
[patent_doc_number] => 20180236129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => IMPLANTS FOR SCULPTING, AUGMENTING OR CORRECTING FACIAL FEATURES SUCH AS THE CHIN
[patent_app_type] => utility
[patent_app_number] => 15/550763
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550763 | IMPLANTS FOR SCULPTING, AUGMENTING OR CORRECTING FACIAL FEATURES SUCH AS THE CHIN | Feb 11, 2016 | Abandoned |
Array
(
[id] => 14482671
[patent_doc_number] => 10328094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Compound from the avermectin family for treating and/or preventing folliculitis
[patent_app_type] => utility
[patent_app_number] => 15/550643
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 4912
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550643 | Compound from the avermectin family for treating and/or preventing folliculitis | Feb 10, 2016 | Issued |
Array
(
[id] => 16518753
[patent_doc_number] => 10869955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Joint fat pad formulations, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/540103
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 22552
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540103 | Joint fat pad formulations, and methods of use thereof | Jan 27, 2016 | Issued |
Array
(
[id] => 11025091
[patent_doc_number] => 20160222046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/003681
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7013
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/003681 | Crystalline form of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof | Jan 20, 2016 | Issued |
Array
(
[id] => 11016755
[patent_doc_number] => 20160213706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'TREATMENT OF MYELOSUPPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/001773
[patent_app_country] => US
[patent_app_date] => 2016-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 29321
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001773
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/001773 | TREATMENT OF MYELOSUPPRESSION | Jan 19, 2016 | Abandoned |
Array
(
[id] => 16198662
[patent_doc_number] => 10723813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => PDGF-B /PDGF-BB binding variants of heparan sulfates
[patent_app_type] => utility
[patent_app_number] => 15/542123
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 55
[patent_no_of_words] => 22497
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542123 | PDGF-B /PDGF-BB binding variants of heparan sulfates | Jan 7, 2016 | Issued |
Array
(
[id] => 13702785
[patent_doc_number] => 20170362347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CARBOXYL CROSS-LINKED CHONDROITIN HYDROGELS AND THEIR USE FOR SOFT TISSUE APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 15/540420
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540420 | CARBOXYL CROSS-LINKED CHONDROITIN HYDROGELS AND THEIR USE FOR SOFT TISSUE APPLICATIONS | Dec 27, 2015 | Abandoned |
Array
(
[id] => 12091253
[patent_doc_number] => 20170348347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'AGENT FOR IMPROVING OCULAR SUBJECTIVE SYMPTOMS AND METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/539771
[patent_app_country] => US
[patent_app_date] => 2015-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6775
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539771 | AGENT FOR IMPROVING OCULAR SUBJECTIVE SYMPTOMS AND METHOD THEREOF | Dec 24, 2015 | Abandoned |
Array
(
[id] => 10756002
[patent_doc_number] => 20160102154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'HYBRID COOPERATIVE COMPLEXES OF HYALURONIC ACID'
[patent_app_type] => utility
[patent_app_number] => 14/974657
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5508
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14974657
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/974657 | Hybrid cooperative complexes of hyaluronic acid | Dec 17, 2015 | Issued |
Array
(
[id] => 10978394
[patent_doc_number] => 20160175337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN'
[patent_app_type] => utility
[patent_app_number] => 14/973037
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12026
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14973037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/973037 | TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN | Dec 16, 2015 | Abandoned |
Array
(
[id] => 10797778
[patent_doc_number] => 20160143935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN'
[patent_app_type] => utility
[patent_app_number] => 14/973055
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15009
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14973055
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/973055 | TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN | Dec 16, 2015 | Abandoned |
Array
(
[id] => 12029515
[patent_doc_number] => 20170319615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'HEPARAN SULPHATES FOR USE IN REPAIR AND/OR REGENERATION OF SKIN'
[patent_app_type] => utility
[patent_app_number] => 15/527972
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 38940
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527972 | Heparan sulphates for use in repair and/or regeneration of skin | Nov 18, 2015 | Issued |
Array
(
[id] => 13548623
[patent_doc_number] => 20180325859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => COMPOSITIONS COMPRISING A COMPOUND FROM THE FAMILY OF AVERMECTINS AND AN AGONIST COMPOUND FOR AT LEAST ONE OF THE RETINOIC ACID RECEPTORS FOR TREATING ACNE
[patent_app_type] => utility
[patent_app_number] => 15/527873
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527873
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527873 | Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne | Nov 18, 2015 | Issued |
Array
(
[id] => 11099577
[patent_doc_number] => 20160296547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2'
[patent_app_type] => utility
[patent_app_number] => 14/945977
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17748
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945977
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/945977 | COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | Nov 18, 2015 | Abandoned |
Array
(
[id] => 11083753
[patent_doc_number] => 20160280718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'NOVEL ANTIBACTERIAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/932285
[patent_app_country] => US
[patent_app_date] => 2015-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23178
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14932285
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/932285 | NOVEL ANTIBACTERIAL AGENTS | Nov 3, 2015 | Abandoned |
Array
(
[id] => 12000179
[patent_doc_number] => 20170304335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING STEVIOSIDES'
[patent_app_type] => utility
[patent_app_number] => 15/523591
[patent_app_country] => US
[patent_app_date] => 2015-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10020
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523591 | Pharmaceutical compositions containing steviosides | Oct 27, 2015 | Issued |
Array
(
[id] => 13689539
[patent_doc_number] => 20170355724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => ANTHELMINTHIC MACROLIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 15/521061
[patent_app_country] => US
[patent_app_date] => 2015-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521061
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521061 | ANTHELMINTHIC MACROLIDE SYNTHESIS | Oct 20, 2015 | Abandoned |
Array
(
[id] => 12001800
[patent_doc_number] => 20170305953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => '14-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE'
[patent_app_type] => utility
[patent_app_number] => 15/517843
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 83581
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517843 | 14-membered ketolides and methods of their preparation and use | Oct 7, 2015 | Issued |
Array
(
[id] => 10669475
[patent_doc_number] => 20160015620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'USE OF CHITOSANS TO INCREASE NAIL GROWTH RATE'
[patent_app_type] => utility
[patent_app_number] => 14/870684
[patent_app_country] => US
[patent_app_date] => 2015-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3732
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14870684
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/870684 | USE OF CHITOSANS TO INCREASE NAIL GROWTH RATE | Sep 29, 2015 | Abandoned |
Array
(
[id] => 10797785
[patent_doc_number] => 20160143942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'COMPOSITIONS AND THEIR USE FOR REMOVING CHOLESTEROL'
[patent_app_type] => utility
[patent_app_number] => 14/865712
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 25349
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14865712
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/865712 | Compositions and their use for removing cholesterol | Sep 24, 2015 | Issued |